Posted On: 07/21/2014 9:31:31 AM
Post# of 30066
I don't know what to think about this from STOCKWIKI--
Beckman-CoulterAmarantus has been working alongside Beckman-Coulter, a labotatory diagnostics supply company. It is rumored that an acquisition of AMBS by Beckman-Coulter is a possibility, given the market potential of LymPro. Beckman-Coulter appears to have the finances, ability, and incentive to do so.
Beckman-Coulter greatly increased the efficiency of the diagnostic Complete Blood Count. At the time, the Coulter method swept laboratories across the world, given that it automated a test which otherwise had to be manually counted by lab technicians.
Beckman-CoulterAmarantus has been working alongside Beckman-Coulter, a labotatory diagnostics supply company. It is rumored that an acquisition of AMBS by Beckman-Coulter is a possibility, given the market potential of LymPro. Beckman-Coulter appears to have the finances, ability, and incentive to do so.
Beckman-Coulter greatly increased the efficiency of the diagnostic Complete Blood Count. At the time, the Coulter method swept laboratories across the world, given that it automated a test which otherwise had to be manually counted by lab technicians.
(0)
(0)
